Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen

Background: Breast cancer (BC) is a heterogeneous disease for which the commonly used chemotherapeutic agents primarily include the anthracyclines (doxorubicin, epirubicin), microtubule inhibitors (paclitaxel, docetaxel, eribulin), and alkylating agents (cyclophosphamide). While these drugs can be h...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatia, Sugandha, Blick, Tony, Pinto, Cletus, Waltham, Mark, Monkman, James, Ivanova, Ekaterina, Pollock, Pamela M., Nagaraj, Shivashankar H., Wiegmans, Adrian P., Haviv, Izhak, Simpson, Kaylene J., Thompson, Erik W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281530/
https://www.ncbi.nlm.nih.gov/pubmed/32365878
http://dx.doi.org/10.3390/cancers12051123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281530/
https://www.ncbi.nlm.nih.gov/pubmed/32365878
http://dx.doi.org/10.3390/cancers12051123

Ejemplares similares